SCHEMBL7939181

SCHEMBL7939181

CC(C)C(=O)OCBr

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2865721 0.80
SCHEMBL681184 0.78 ELANE (0.34)
Ethylene Glycol Diisobutanoate SCHEMBL843146 0.78 TSHR (0.36)
SCHEMBL31349332 0.76 MAPT (0.32)
SCHEMBL27542631 0.75
SCHEMBL79434 0.75
SCHEMBL216117 0.75
SCHEMBL80284 0.75
SCHEMBL30902202 0.75 ALDH1A1 (0.37)
SCHEMBL22597524 0.75 ALDH1A1 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115925640-B ((3-Carbamoyl-5-fluoropyrazin-2-yl) oxy) methyl isobutyrate and preparation method and application thereof 中国人民解放军军事科学院军事医学研究院 2025-03-28 CN claimed
CN-115925640-A ((3-carbamoyl-5-fluoropyrazin-2-yl) oxy) methyl isobutyrate and preparation method and application thereof 中国人民解放军军事科学院军事医学研究院 2023-04-07 CN claimed
US-12637481-B2 Boronic acid derivatives and therapeutic uses thereof QPEX BIOPHARMA, INC. (US) 2026-05-26 US disclosed
CN-115925640-B ((3-Carbamoyl-5-fluoropyrazin-2-yl) oxy) methyl isobutyrate and preparation method and application thereof 中国人民解放军军事科学院军事医学研究院 2025-03-28 CN disclosed
CN-118541355-A Solid forms of a compound, methods of preparation and uses thereof 中国人民解放军军事科学院军事医学研究院 2024-08-23 CN disclosed
US-20240209014-A1 NOVEL SPINOSYN PRODRUGS ACIES BIO D.O.O. (SI) 2024-06-27 US disclosed
US-20240209014-A1 NOVEL SPINOSYN PRODRUGS ACIES BIO D.O.O. (SI) 2024-06-27 US disclosed
CN-116687932-B Medical application of ((3-carbamoyl-5-fluoropyrazin-2-yl) oxy) methyl isobutyrate 中国人民解放军军事科学院军事医学研究院 2024-03-29 CN disclosed
WO-2023169119-A1 SOLID FORM OF COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF 中国人民解放军军事科学院军事医学研究院 2023-09-14 WO disclosed
CN-116687932-A Medical application of ((3-carbamoyl-5-fluoropyrazin-2-yl) oxy) methyl isobutyrate 中国人民解放军军事科学院军事医学研究院 2023-09-05 CN disclosed
US-20230151029-A1 BORONIC ACID DERIVATIVES AND THERAPEUTIC USES THEREOF QPEX BIOPHARMA, INC. 2023-05-18 US disclosed
WO-2013009791-A1 PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO DOW AGROSCIENCES LLC (US) 2013-01-17 WO disclosed
US-20130019348-A1 PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO DOW AGROSCIENCES LLC (US) 2013-01-17 US disclosed
CN-1420881-A Beta-amino acid derivs. as inhibitors of matrix metalloproteases and TNF-alpha BRISTOL MYERS SQUIBB PHARMACEU (US) 2003-05-28 CN disclosed
US-6239145-B1 USABLE IN ACQUIRING INFORMATION ABOUT ACTIVE OXYGEN OR IN VIVO FREE RADICALS AS BIOLOGICAL IMAGES SUCH AS MAGNETIC RESONANCE IMAGES OR MAGNETOENCEPHALOGRAMS; DAIITCHI RADIOISOTOPE LABORATORIES, LTD. (JP) 2001-05-29 US disclosed
EP-0995740-A1 NOVEL NITROXYL COMPOUNDS AND DRUGS AND REAGENTS CONTAINING THE SAME AS THE ACTIVE INGREDIENT DAIICHI RADIOISOTOPE LABORATORIES, LTD. (JP) 2000-04-26 EP disclosed
US-4716158-A CEPHALOSPORINS SUITABLE FOR ORAL ADMINISTRATION SANKYO COMPANY LIMITED (JP) 1987-12-29 US disclosed
EP-0049118-B1 CEPHALOSPORIN DERIVATIVES, THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM SANKYO COMPANY LIMITED (JP) 1986-04-23 EP disclosed
US-4486425-A ANTIBIOTICS SANKYO COMPANY LIMITED (JP) 1984-12-04 US disclosed
EP-0049118-A2 Cephalosporin derivatives, their preparation and compositions containing them SANKYO COMPANY LIMITED (JP) 1982-04-07 EP disclosed